{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:49:50Z","timestamp":1793332190311,"version":"4.5.0"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T00:00:00Z","timestamp":1602720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40123-020-00309-y","type":"journal-article","created":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T10:03:22Z","timestamp":1602756202000},"page":"833-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Lipid Keratopathy: A Review of Pathophysiology, Differential Diagnosis, and Management"],"prefix":"10.1007","volume":"9","author":[{"given":"MacGregor N.","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-6250","authenticated-orcid":false,"given":"Majid","family":"Moshirfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armaan","family":"Amin-Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean P.","family":"Ouano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmyne","family":"Ronquillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip C.","family":"\u00a0Hoopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,15]]},"reference":[{"key":"309_CR1","doi-asserted-by":"crossref","unstructured":"Alfonso E, Arrellanes L, Boruchoff SA, Ormerod LD, Albert DM. Idiopathic bilateral lipid keratopathy. Br J Ophthalmol. 1988. 72(5):338\u201343.","DOI":"10.1136\/bjo.72.5.338"},{"issue":"2","key":"309_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF01705018","volume":"22","author":"P Baumgarten","year":"1876","unstructured":"Baumgarten P. Ophthalmologisch-histologische Mittheilungen. Graefe\u2019s Arch f\u00fcr Ophthalmol. 1876;22(2):185\u2013203. https:\/\/doi.org\/10.1007\/BF01705018.","journal-title":"Graefe\u2019s Arch f\u00fcr Ophthalmol"},{"issue":"4","key":"309_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/01.CIR.18.4.519","volume":"18","author":"DG Cogan","year":"1958","unstructured":"Cogan DG, Kuwabara T. Lipid keratopathy and atheroma. Circulation. 1958;18(4):519\u201325.","journal-title":"Circulation"},{"issue":"12","key":"309_CR4","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S0161-6420(85)34092-7","volume":"92","author":"JO Croxatto","year":"1985","unstructured":"Croxatto JO, Dodds CM, Dodds R. Bilateral and massive lipoidal infiltration of the cornea (secondary lipoidal degeneration). Ophthalmology. 1985;92(12):1686\u201390.","journal-title":"Ophthalmology"},{"issue":"6","key":"309_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/archopht.1970.00990030678002","volume":"83","author":"RL Jack","year":"1970","unstructured":"Jack RL. Lipid keratopathy. Arch Ophthalmol. 1970;83(6):678. https:\/\/doi.org\/10.1001\/archopht.1970.00990030678002.","journal-title":"Arch Ophthalmol"},{"key":"309_CR6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/bjo.77.4.248","volume":"77","author":"A Silva-Ara\u00fatjo","year":"1993","unstructured":"Silva-Ara\u00fatjo A, Tavares MA, Lemos MM, Soares MI, Castro-Correia J, Salgado-Borges J. Primary lipid keratopathy: a morphological and biochemical assessment. Br J Ophthalmol. 1993;77:248\u201350.","journal-title":"Br J Ophthalmol."},{"issue":"1","key":"309_CR7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9394(74)90004-X","volume":"78","author":"BS Fine","year":"1974","unstructured":"Fine BS, Townsend WM, Zimmerman LE, Lashkari MH. Primary lipoidal degeneration of the cornea. Am J Ophthalmol. 1974;78(1):12\u201323.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"309_CR8","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1001\/archopht.1977.04450030098013","volume":"95","author":"LA Shapiro","year":"1977","unstructured":"Shapiro LA, Farkas TG. Lipid keratopathy following corneal hydrops. Arch Ophthalmol. 1977;95(3):456\u20138.","journal-title":"Arch Ophthalmol"},{"key":"309_CR9","first-page":"1","volume":"2012","author":"RC Ghanem","year":"2012","unstructured":"Ghanem RC, Ghanem VC, Victor G, Alves MR. Bilateral progressive idiopathic annular lipid keratopathy. Case Rep Ophthalmol Med. 2012;2012:1\u20134.","journal-title":"Case Rep Ophthalmol Med"},{"issue":"10","key":"309_CR10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/archopht.123.10.1435","volume":"123","author":"KU Loeffler","year":"2005","unstructured":"Loeffler KU. Unusual idiopathic lipid keratopathy: a newly recognized entity? Arch Ophthalmol. 2005;123(10):1435.","journal-title":"Arch Ophthalmol"},{"key":"309_CR11","unstructured":"World Health Organization (WHO). Future approaches to trachoma control: report from a global scientific meeting, Geneva, 17\u201320 June 1996. Geneva: WHO; 1996. https:\/\/apps.who.int\/iris\/handle\/10665\/63413. Accessed July 9 2020."},{"issue":"4","key":"309_CR12","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pntd.0000217","volume":"2","author":"JE Allen","year":"2008","unstructured":"Allen JE, Adjei O, Bain O, et al. Of mice, cattle, and humans: the immunology and treatment of river blindness. LoS Negl Trop Dis. 2008;2(4):e217.","journal-title":"LoS Negl Trop Dis"},{"issue":"3","key":"309_CR13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/cxo.12110","volume":"97","author":"YW Goh","year":"2014","unstructured":"Goh YW, Mcghee CN, Patel DV, Barnes R, Misra S. Treatment of herpes zoster related corneal neovascularisation and lipid keratopathy by photodynamic therapy. Clin Exp Optom. 2014;97(3):274\u20137.","journal-title":"Clin Exp Optom"},{"issue":"2","key":"309_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","volume":"10","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Cheng SF, Dastjerdi MH, Ferrari G, Dana R. Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin). Ocul Surf. 2012;10(2):67\u201383.","journal-title":"Ocul Surf"},{"issue":"1","key":"309_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clae.2013.07.011","volume":"37","author":"EY Li","year":"2014","unstructured":"Li EY, Jhanji V. Massive lipid keratopathy after Elizabethkingia meningosepticum keratitis. Contact Lens Anterior Eye. 2014;37(1):55\u20136. https:\/\/doi.org\/10.1016\/j.clae.2013.07.011.","journal-title":"Contact Lens Anterior Eye"},{"key":"309_CR16","doi-asserted-by":"publisher","unstructured":"Hamill CE, Bozorg S, Peggy Chang H-Y, Lee H, Sayegh RR, Shukla AN, et al. Corneal alkali burns. Int Ophthalmol Clin. 2013;53(4):185\u201394. https:\/\/doi.org\/10.1097\/IIO.0b013e31829ceefa.","DOI":"10.1097\/IIO.0b013e31829ceefa"},{"key":"309_CR17","doi-asserted-by":"crossref","unstructured":"Cursiefen C, Kruse FE. New aspects of angiogenesis in the cornea. In: Reinhard T, Larkin D, editors. Cornea and external eye disease. Essentials in ophthalmology. Berlin Heidelberg: Springer; 2006. p. 83\u201399.","DOI":"10.1007\/3-540-31226-9_7"},{"key":"309_CR18","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.1097\/ICL.0000000000000494","volume":"44","author":"YC Sun","year":"2018","unstructured":"Sun YC, Yang LC, Hu FR, Lin CT, Chen YM, Chen WL. In vivo confocal microscopic study of hard contact lens-induced lipid keratopathy secondary to corneal neovascularization in a rabbit hypercholesterolemic model. Eye Contact Lens. 2018;44:S325\u201332.","journal-title":"Eye Contact Lens"},{"key":"309_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.exer.2015.11.012","volume":"145","author":"N Afsharkhamseh","year":"2016","unstructured":"Afsharkhamseh N, Movahedan A, Gidfar S, et al. Stability of limbal stem cell deficiency after mechanical and thermal injuries in mice. Exp Eye Res. 2016;145:88\u201392.","journal-title":"Exp Eye Res"},{"issue":"1","key":"309_CR20","first-page":"182","volume":"8","author":"NS Abdelfattah","year":"2015","unstructured":"Abdelfattah NS, Amgad M, Zayed AA, et al. Clinical correlates of common corneal neovascular diseases: a literature review. Int J Ophthalmol. 2015;8(1):182\u201393.","journal-title":"Int J Ophthalmol"},{"issue":"6","key":"309_CR21","first-page":"604","volume":"14","author":"MR Dana","year":"1995","unstructured":"Dana MR, Schaumberg DA, Kowal VO, et al. Corneal neovascularization after penetrating keratoplasty. Cornea. 1995;14(6):604\u20139.","journal-title":"Cornea"},{"key":"309_CR22","doi-asserted-by":"crossref","unstructured":"Shah R, Puranik C, Mohamed A, Sangwan VS. Cultivated limbal epithelial transplantation and penetrating keratoplasty postchemical injury: a 14-year follow-up. BMJ Case Rep. 2017;2017:bcr2016217372.","DOI":"10.1136\/bcr-2016-217372"},{"key":"309_CR23","doi-asserted-by":"crossref","unstructured":"Bachmann B, Taylor RS, Cursiefen C. Corneal neovascularization as a risk factor for graft failure and rejection after keratoplasty. Ophthalmology. 2010;117(7):1300\u20131305.e7.","DOI":"10.1016\/j.ophtha.2010.01.039"},{"issue":"2","key":"309_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1442-9071.2010.02197.x","volume":"38","author":"DP Pi\u00f1ero","year":"2010","unstructured":"Pi\u00f1ero DP, Alio JL. Intracorneal ring segments in ectatic corneal disease\u2014a review. Clin Exp Ophthalmol. 2010;38(2):154\u201367. https:\/\/doi.org\/10.1111\/j.1442-9071.2010.02197.x.","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"309_CR25","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3928\/1081597X-20191010-02","volume":"35","author":"M-J Bautista-Llamas","year":"2019","unstructured":"Bautista-Llamas M-J, S\u00e1nchez-Gonz\u00e1lez MC, L\u00f3pez-Izquierdo I, et al. Complications and explantation reasons in intracorneal ring segments (ICRS) implantation: a systematic review. J Refract Surg. 2019;35(11):740\u20137. https:\/\/doi.org\/10.3928\/1081597X-20191010-02.","journal-title":"J Refract Surg"},{"issue":"4","key":"309_CR26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.icl.0000194530.68528.14","volume":"32","author":"LT Ly","year":"2006","unstructured":"Ly LT, McCulley JP, Verity SM, Cavanagh HD, Bowman RW, Petroll WM. Evaluation of intrastromal lipid deposits after intacs implantation using in vivo confocal microscopy. Eye Contact Lens. 2006;32(4):211\u20135.","journal-title":"Eye Contact Lens"},{"key":"309_CR27","doi-asserted-by":"crossref","unstructured":"Barchiesi BJ, Eckel RH, Ellis PP. The cornea and disorders of lipid metabolism. Surv Ophthalmol. 1991;36(1):1\u201322.","DOI":"10.1016\/0039-6257(91)90205-T"},{"issue":"3","key":"309_CR28","first-page":"167","volume":"9","author":"E Gjone","year":"1988","unstructured":"Gjone E. Familial lecithin: cholesterol acyltransferase (LCAT) deficiency: an updated review spring 1988. Ophthalm Genet. 1988;9(3):167\u20139.","journal-title":"Ophthalm Genet"},{"issue":"7\u20138","key":"309_CR29","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinbiochem.2014.08.014","volume":"48","author":"R Saeedi","year":"2015","unstructured":"Saeedi R, Li M, Frohlich J. A review on lecithin: cholesterol acyltransferase deficiency. Clin Biochem. 2015;48(7\u20138):472\u20135.","journal-title":"Clin Biochem"},{"key":"309_CR30","doi-asserted-by":"crossref","unstructured":"Chu FC, Kuwabara T, Cogan DG, Schaefer EJ, Brewer HB. Ocular manifestations of familial high-density lipoprotein deficiency (Tangier disease). Arch Ophthalmol. 1979;97(10):1926\u20138. http:\/\/archopht.jamanetwork.com\/article.aspx?articleid=633168.","DOI":"10.1001\/archopht.1979.01020020374020"},{"key":"309_CR31","doi-asserted-by":"publisher","unstructured":"Herrmann WA, von Mohrenfels CW, Lohmann CP. Confocal microscopy and corneal sensitivity in a patient with corneal manifestations of tangier disease. Cornea. 2004;23(8):825\u20137. https:\/\/doi.org\/10.1097\/01.ico.0000126331.84852.f6.","DOI":"10.1097\/01.ico.0000126331.84852.f6"},{"issue":"5","key":"309_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/jcp.49.5.407","volume":"49","author":"AF Winder","year":"1996","unstructured":"Winder AF, Alexander R, Garner A, et al. The pathology of cornea in Tangier disease (familial high density lipoprotein deficiency). J Clin Pathol. 1996;49(5):407\u201310. https:\/\/doi.org\/10.1136\/jcp.49.5.407.","journal-title":"J Clin Pathol"},{"key":"309_CR33","unstructured":"Burnett JR, Hooper AJ, McCormick SP, Hegele RA. Tangier disease. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993\u20132020."},{"key":"309_CR34","doi-asserted-by":"publisher","unstructured":"Chan AT, Ulate R, Goldich Y, Rootman DS, Chan CC. Terrien marginal degeneration: Clinical characteristics and outcomes. Am J Ophthalmol. 2015;160(5):867\u2013872.e1. https:\/\/doi.org\/10.1016\/j.ajo.2015.07.031.","DOI":"10.1016\/j.ajo.2015.07.031"},{"issue":"2","key":"309_CR35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1159\/000478925","volume":"8","author":"K Oikonomakis","year":"2017","unstructured":"Oikonomakis K, Petrelli M, Andreanos K, et al. Corneal neovascularization with associated lipid keratopathy in a patient with obstructive sleep apnea-hypopnea syndrome using a continuous positive airway pressure machine. Case Rep Ophthalmol. 2017;8(2):416\u201320.","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"309_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1034\/j.1600-0420.2003.00025.x","volume":"81","author":"M Morisawa","year":"2003","unstructured":"Morisawa M, Yamagami S, Inoki T, Ochiai M, Tsuru T. Bilateral centripetal lipid keratopathy with diffuse anterior scleritis. Acta Ophthalmol Scand. 2003;81(2):202\u20133. https:\/\/doi.org\/10.1034\/j.1600-0420.2003.00025.x.","journal-title":"Acta Ophthalmol Scand"},{"issue":"11","key":"309_CR37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1136\/bjo.26.11.503","volume":"26","author":"I Mann","year":"1942","unstructured":"Mann I, Pullinger BD. The pathology of cholesterin and fat deposition in mustard gas injuries of the cornea. Br J Ophthalmol. 1942;26(11):503\u20137. https:\/\/doi.org\/10.1136\/bjo.26.11.503.","journal-title":"Br J Ophthalmol"},{"key":"309_CR38","doi-asserted-by":"publisher","unstructured":"Jafarinasab M-R, Zarei-Ghanavati S, Kanavi MR, Karimian F, Soroush M-R, Javadi M-A. Confocal microscopy in chronic and delayed mustard gas keratopathy. Cornea. 2010;29(8):889\u201394. https:\/\/doi.org\/10.1097\/ICO.0b013e3181ca324c.","DOI":"10.1097\/ICO.0b013e3181ca324c"},{"key":"309_CR39","doi-asserted-by":"publisher","unstructured":"Miserocchi E, Baltatzis S, Foster CS. A case of atypical Cogan\u2019s syndrome with uncommon corneal findings. Cornea. 2001;20(5):540\u20132. https:\/\/doi.org\/10.1097\/00003226-200107000-00021.","DOI":"10.1097\/00003226-200107000-00021"},{"key":"309_CR40","doi-asserted-by":"crossref","unstructured":"Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27\u201330. http:\/\/www.nature.com\/articles\/nm0195-27.","DOI":"10.1038\/nm0195-27"},{"issue":"2","key":"309_CR41","first-page":"264","volume":"104","author":"D Azar","year":"2006","unstructured":"Azar D. Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing. Trans Am Ophthalmol Soc. 2006;104(2):264\u2013302.","journal-title":"Trans Am Ophthalmol Soc."},{"key":"309_CR42","doi-asserted-by":"publisher","unstructured":"Notara M, Lentzsch A, Coroneo M, Cursiefen C. The role of limbal epithelial stem cells in regulating corneal (lymph)angiogenic privilege and the micromilieu of the limbal niche following UV exposure. Stem Cells Int. 2018;2018:1\u201315. https:\/\/doi.org\/10.1155\/2018\/8620172.","DOI":"10.1155\/2018\/8620172"},{"issue":"3","key":"309_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","volume":"29","author":"D Ellenberg","year":"2010","unstructured":"Ellenberg D, Azar DT, Hallak JA, et al. Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res. 2010;29(3):208\u201348. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.01.002.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"309_CR44","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1096\/fj.01-0815fje","volume":"16","author":"G Pintucci","year":"2002","unstructured":"Pintucci G, Moscatelli D, Saponara F, et al. Lack of ERK activation and cell migration in FGF-2-deficient endothelial cells. FASEB J. 2002;16(6):598\u2013600. https:\/\/doi.org\/10.1096\/fj.01-0815fje.","journal-title":"FASEB J"},{"key":"309_CR45","doi-asserted-by":"crossref","unstructured":"Lee HS, Schlereth SL, Park EY, Emami-Naeini P, Chauhan SK, Dana R. A novel pro-angiogenic function for interferon-\u03b3-secreting natural killer cells. Investig Ophthalmol Vis Sci. 2014;55(5):2885\u201392.","DOI":"10.1167\/iovs.14-14093"},{"issue":"20","key":"309_CR46","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1242\/dev.00721","volume":"130","author":"RV Hoch","year":"2003","unstructured":"Hoch RV. Roles of PDGF in animal development. Development. 2003;130(20):4769\u201384. https:\/\/doi.org\/10.1242\/dev.00721.","journal-title":"Development"},{"key":"309_CR47","doi-asserted-by":"crossref","unstructured":"Augustin HG, Young Koh G, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin\u2013Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165\u201377. http:\/\/www.nature.com\/articles\/nrm2639.","DOI":"10.1038\/nrm2639"},{"issue":"4","key":"309_CR48","first-page":"625","volume":"9","author":"NS Abdelfattah","year":"2016","unstructured":"Abdelfattah NS, Amgad M, Zayed AA. Host immune cellular reactions in corneal neovascularization. Int J Ophthalmol. 2016;9(4):625\u201333.","journal-title":"Int J Ophthalmol"},{"key":"309_CR49","unstructured":"Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443(7114):993\u20137. http:\/\/www.nature.com\/articles\/nature05249."},{"issue":"4","key":"309_CR50","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/bjo.2006.107417","volume":"91","author":"BK Ambati","year":"2007","unstructured":"Ambati BK, Patterson E, Jani P, et al. Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. Br J Ophthalmol. 2007;91(4):505\u20138. https:\/\/doi.org\/10.1136\/bjo.2006.107417.","journal-title":"Br J Ophthalmol"},{"key":"309_CR51","doi-asserted-by":"publisher","unstructured":"Cursiefen C, Chen L, Saint-Geniez M, et al. Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci USA. 2006;103(30):11405\u201310. https:\/\/doi.org\/10.1073\/pnas.0506112103.","DOI":"10.1073\/pnas.0506112103"},{"key":"309_CR52","doi-asserted-by":"publisher","unstructured":"Tsai RJ-F, Tseng SCG. Human allograft limbal transplantation for corneal surface reconstruction. Cornea. 1994;13(5):389\u2013400. https:\/\/doi.org\/10.1097\/00003226-199409000-00003.","DOI":"10.1097\/00003226-199409000-00003"},{"issue":"3","key":"309_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/08820530902801478","volume":"24","author":"P Lim","year":"2009","unstructured":"Lim P, Fuchsluger TA, Jurkunas UV. Limbal stem cell deficiency and corneal neovascularization. Semin Ophthalmol. 2009;24(3):139\u201348. https:\/\/doi.org\/10.1080\/08820530902801478.","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"309_CR54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/74651","volume":"6","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6(4):389\u201395.","journal-title":"Nat Med"},{"issue":"5","key":"309_CR55","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2353\/ajpath.2009.080515","volume":"175","author":"E-S Chung","year":"2009","unstructured":"Chung E-S, Chauhan SK, Jin Y, et al. Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol. 2009;175(5):1984\u201392.","journal-title":"Am J Pathol"},{"issue":"3","key":"309_CR56","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/bjophthalmol-2015-306686","volume":"100","author":"LA Faraj","year":"2016","unstructured":"Faraj LA, Said DG, Al-Aqaba M, Otri AM, Dua HS. Clinical evaluation and characterisation of corneal vascularisation. Br J Ophthalmol. 2016;100(3):315\u201322.","journal-title":"Br J Ophthalmol"},{"key":"309_CR57","doi-asserted-by":"publisher","unstructured":"Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea. 2006;25(4):443\u20137. https:\/\/doi.org\/10.1097\/01.ico.0000183485.85636.ff.","DOI":"10.1097\/01.ico.0000183485.85636.ff"},{"issue":"2","key":"309_CR58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1350-9462(02)00004-6","volume":"21","author":"S Crispin","year":"2002","unstructured":"Crispin S. Ocular lipid deposition and hyperlipoproteinaemia. Prog Retin Eye Res. 2002;21(2):169\u2013224.","journal-title":"Prog Retin Eye Res."},{"key":"309_CR59","first-page":"363","volume":"43","author":"M Friedman","year":"1962","unstructured":"Friedman M, Byers SO. Excess lipid leakage: a property of very young vascular endothelium. Br J Exp Pathol. 1962;43:363\u201372.","journal-title":"Br J Exp Pathol."},{"issue":"1","key":"309_CR60","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Hofmann-Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U. Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol. 2003;87(1):101\u20136.","journal-title":"Br J Ophthalmol"},{"key":"309_CR61","doi-asserted-by":"crossref","unstructured":"Silva-Ara\u00fatjo A, Tavares MA, Lemos MM, Soares MI, Castro-Correia J, Salgado-Borges J. Primary lipid keratopathy: a morphological and biochemical assessment. Br J Ophthalmol. 1993;77(4):248\u201350.","DOI":"10.1136\/bjo.77.4.248"},{"issue":"2","key":"309_CR62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1542-0124(12)70130-1","volume":"1","author":"KL Mayer","year":"2003","unstructured":"Mayer KL, Nordlund ML, Schwartz GS, Holland EJ. Keratopathy in congenital aniridia. Ocul Surf. 2003;1(2):74\u20139.","journal-title":"Ocul Surf"},{"issue":"1","key":"309_CR63","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ophtha.2011.06.044","volume":"119","author":"E Di Iorio","year":"2012","unstructured":"Di Iorio E, Kaye SB, Ponzin D, et al. Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutations. Ophthalmology. 2012;119(1):74\u201383.","journal-title":"Ophthalmology."},{"issue":"2","key":"309_CR64","first-page":"298","volume":"119","author":"N Koizumi","year":"2001","unstructured":"Koizumi N, Inatomi T, Suzuki T, Sotozono C, Kinoshita S. Cultivated corneal epithelial transplantation for ocular surface reconstruction in acute phase of Stevens-Johnson syndrome. Arch Ophthalmol. 2001;119(2):298\u2013300.","journal-title":"Arch Ophthalmol"},{"key":"309_CR65","doi-asserted-by":"crossref","unstructured":"Dua HS, Joseph A, Shanmuganathan VA, Jones RE. Stem cell differentiation and the effects of deficiency. Eye. 2003;17(8):877\u201385. http:\/\/www.nature.com\/articles\/6700573.","DOI":"10.1038\/sj.eye.6700573"},{"key":"309_CR66","doi-asserted-by":"publisher","unstructured":"Hatch KM, Dana R. The structure and function of the limbal stem cell and the disease states associated with limbal stem cell deficiency. Int Ophthalmol Clin. 2009;49(1):43\u201352. https:\/\/doi.org\/10.1097\/IIO.0b013e3181924e54.","DOI":"10.1097\/IIO.0b013e3181924e54."},{"key":"309_CR67","doi-asserted-by":"publisher","unstructured":"Ozerdem U, Alitalo K, Salven P, Li A. Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis. Investig Ophthalmol Vis Sci. 2005;46(10):3502\u20136. https:\/\/doi.org\/10.1167\/iovs.05-0309.","DOI":"10.1167\/iovs.05-0309"},{"issue":"3","key":"309_CR68","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP. Ocular neovascularization: an epidemiologic review. Surv Ophthalmol. 1998;43(3):245\u201369.","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"309_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jcma.2014.10.002","volume":"78","author":"CC Hsu","year":"2015","unstructured":"Hsu CC, Chang HM, Lin TC, et al. Corneal neovascularization and contemporary antiangiogenic therapeutics. J Chin Med Assoc. 2015;78(6):323\u201330. https:\/\/doi.org\/10.1016\/j.jcma.2014.10.002.","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"309_CR70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/00003226-199103000-00013","volume":"10","author":"JA Dur\u00e1n","year":"1991","unstructured":"Dur\u00e1n JA, Rodriguez-Ares MT. Idiopathic lipid corneal degeneration. Cornea. 1991;10(2):166\u20139.","journal-title":"Cornea"},{"issue":"35","key":"309_CR71","doi-asserted-by":"crossref","first-page":"e16589","DOI":"10.1097\/MD.0000000000016589","volume":"98","author":"Y Pang","year":"2019","unstructured":"Pang Y, Zhang Q, Bao Y. A CARE-compliant article: ipsilateral progressive idiopathic lipid keratopathy: a case report. Medicine (Baltimore). 2019;98(35):e16589.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"309_CR72","first-page":"22","volume":"101","author":"AR Fielder","year":"1981","unstructured":"Fielder AR, Winder AF, Sheraidah GA, Cooke ED. Problems with corneal arcus. Trans Ophthalmol Soc UK. 1981;101(1):22\u20136.","journal-title":"Trans Ophthalmol Soc UK"},{"key":"309_CR73","doi-asserted-by":"publisher","unstructured":"Cogan DG. Arcus senilis. AMA Arch Ophthalmol. 1959;61(4):553\u201360. https:\/\/doi.org\/10.1001\/archopht.1959.00940090555009.","DOI":"10.1001\/archopht.1959.00940090555009"},{"issue":"6","key":"309_CR74","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1001\/jama.1973.03230060052030","volume":"226","author":"JL Smith","year":"1973","unstructured":"Smith JL. Unilateral arcus senilis: sign of occlusive disease of the carotid artery. JAMA. 1973;226(6):676. https:\/\/doi.org\/10.1001\/jama.1973.03230060052030.","journal-title":"JAMA"},{"key":"309_CR75","doi-asserted-by":"publisher","unstructured":"Weiss JS, Khemichian AJ. Differential diagnosis of schnyder corneal dystrophy. In: corneal dystrophies. Basel: Karger; 2011:67\u201396. https:\/\/doi.org\/10.1159\/000324078.","DOI":"10.1159\/000324078"},{"key":"309_CR76","doi-asserted-by":"publisher","unstructured":"Chang J-H, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12(4):242\u20139. https:\/\/doi.org\/10.1097\/00055735-200108000-00002.","DOI":"10.1097\/00055735-200108000-00002"},{"key":"309_CR77","doi-asserted-by":"publisher","unstructured":"Igarashi T, Takahashi H. Photodynamic therapy for neovascularization in lipid keratopathy. J Nippon Med Sch. 2010;77(2):66. https:\/\/doi.org\/10.1272\/jnms.77.66.","DOI":"10.1272\/jnms.77.66"},{"key":"309_CR78","doi-asserted-by":"publisher","unstructured":"Yoon KC, You IC, Kang IS, Im SK, Ahn JK, Park YG, et al. Photodynamic therapy with verteporfin for corneal neovascularization. Am J Ophthalmol. 2007;144(3):390\u20135.e1. https:\/\/doi.org\/10.1016\/j.ajo.2007.05.028.","DOI":"10.1016\/j.ajo.2007.05.028"},{"issue":"4","key":"309_CR79","first-page":"212","volume":"82","author":"AA Al-Abdullah","year":"2011","unstructured":"Al-Abdullah AA, Al-Assiri A. Resolution of bilateral corneal neovascularization and lipid keratopathy after photodynamic therapy with verteporfin. Optom\u2013J Am Optom Assoc. 2011;82(4):212\u20134.","journal-title":"Optom\u2013J Am Optom Assoc"},{"issue":"6","key":"309_CR80","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/bjo.2003.035071","volume":"88","author":"BJ Brooks","year":"2004","unstructured":"Brooks BJ. Photodynamic therapy for corneal neovascularisation and lipid degeneration. Br J Ophthalmol. 2004;88(6):840. https:\/\/doi.org\/10.1136\/bjo.2003.035071.","journal-title":"Br J Ophthalmol."},{"key":"309_CR81","doi-asserted-by":"publisher","unstructured":"Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina. 2006;26(4):383\u201390. https:\/\/doi.org\/10.1097\/01.iae.0000238561.99283.0e.","DOI":"10.1097\/01.iae.0000238561.99283.0e"},{"key":"309_CR82","doi-asserted-by":"crossref","unstructured":"Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113(10):1695\u20131705.e6.","DOI":"10.1016\/j.ophtha.2006.05.064"},{"issue":"3","key":"309_CR83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/eye.2015.259","volume":"30","author":"LC Olmos","year":"2016","unstructured":"Olmos LC, Sayed MS, Moraczewski AL, et al. Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab. Eye. 2016;30(3):463\u201372.","journal-title":"Ey."},{"key":"309_CR84","doi-asserted-by":"publisher","unstructured":"Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions. Retina. 2007;27(2):141\u20139. https:\/\/doi.org\/10.1097\/IAE.0b013e31802eff83.","DOI":"10.1097\/IAE.0b013e31802eff83"},{"issue":"9","key":"309_CR85","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/ICO.0b013e31819839f9","volume":"28","author":"JY Oh","year":"2009","unstructured":"Oh JY, Kim MK, Wee WR. Subconjunctival and intracorneal bevacizumab injection for corneal neovascularization in lipid keratopathy. Cornea. 2009;28(9):1070\u20133.","journal-title":"Cornea"},{"issue":"1","key":"309_CR86","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0b013e3181e458c5","volume":"30","author":"HS Chu","year":"2011","unstructured":"Chu HS, Hu FR, Yang CM, et al. Subconjunctival injection of bevacizumab in the treatment of corneal neovascularization associated with lipid deposition. Cornea. 2011;30(1):60\u20136.","journal-title":"Cornea"},{"issue":"11","key":"309_CR87","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/ICO.0b013e31825ec407","volume":"32","author":"HS Chu","year":"2013","unstructured":"Chu HS, Chen TC, Hu FR, Chen WL. Recurrence of corneal neovascularization associated with lipid deposition after subconjunctival injection of bevacizumab. Cornea. 2013;32(11):1446\u201353.","journal-title":"Cornea"},{"key":"309_CR88","doi-asserted-by":"publisher","unstructured":"Castro-Rebollo M, Montes-Moll\u00f3n MA, P\u00e9rez-Rico C, Teus MA. Effectiveness of topical bevacizumab in bilateral primary lipid keratopathy [Eficacia de bevacizumab t\u00f3pico en queratopat\u00eda lipoidea bilateral primaria]. Arch Soc Esp Oftalmol. 2011;86(11):374\u20136. https:\/\/doi.org\/10.1016\/j.oftale.2011.05.006.","DOI":"10.1016\/j.oftale.2011.05.006"},{"issue":"7","key":"309_CR89","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/ICO.0000000000000419","volume":"34","author":"U Elbaz","year":"2015","unstructured":"Elbaz U, Mireskandari K, Shen C, Ali A. Corneal fine needle diathermy with adjuvant bevacizumab to treat corneal neovascularization in children. Cornea. 2015;34(7):773\u20137.","journal-title":"Cornea"},{"issue":"5","key":"309_CR90","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/08820538.2015.1123738","volume":"32","author":"R Hussain","year":"2017","unstructured":"Hussain R, Savant V. Fine-needle diathermy with simultaneous subconjunctival bevacizumab. Semin Ophthalmol. 2017;32(5):550\u20132. https:\/\/doi.org\/10.3109\/08820538.2015.1123738.","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"309_CR91","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0b013e3182542613","volume":"32","author":"M Papathanassiou","year":"2013","unstructured":"Papathanassiou M, Theodoropoulou S, Analitis A, Tzonou A, Theodossiadis PG. Vascular endothelial growth factor inhibitors for treatment of corneal neovascularization: a meta-analysis. Cornea. 2013;32(4):435\u201344.","journal-title":"Cornea"},{"issue":"10","key":"309_CR92","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00417-009-1101-y","volume":"247","author":"M Saravia","year":"2009","unstructured":"Saravia M, Zapata G, Ferraiolo P, Racca L, Berra A. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefe\u2019s Arch Clin Exp Ophthalmol. 2009;247(10):1409\u201316.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"12","key":"309_CR93","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1167\/iovs.11-7871","volume":"52","author":"MH Dastjerdi","year":"2011","unstructured":"Dastjerdi MH, Sadrai Z, Saban DR, Zhang Q, Dana R. Corneal penetration of topical and subconjunctival bevacizumab. Investig Opthalmol Vis Sci. 2011;52(12):8718.","journal-title":"Investig Opthalmol Vis Sci"},{"issue":"4","key":"309_CR94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi MH, Al-Arfaj KM, Nallasamy N, Hamrah P, Jurkunas UV, Pineda R, et al. Topical bevacizumab in the treatment of corneal neovascularization; results of a prospective, open-label, noncomparative study. Arch Ophthalmol. 2009;127(4):381\u20139.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"309_CR95","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1001\/archopht.124.10.1478","volume":"124","author":"MC Gillies","year":"2006","unstructured":"Gillies MC. What we don\u2019t know about avastin might hurt us. Arch Ophthalmol. 2006;124(10):1478.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"309_CR96","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.ophtha.2008.02.013","volume":"115","author":"SW Kim","year":"2008","unstructured":"Kim SW, Ha BJ, Kim EK, Tchah H, Kim T. The effect of topical bevacizumab on corneal neovascularization. Ophthalmology. 2008;115(6):e33\u20138.","journal-title":"Ophthalmology."},{"issue":"4","key":"309_CR97","doi-asserted-by":"publisher","first-page":"e94205","DOI":"10.1371\/journal.pone.0094205","volume":"9","author":"W-L Chen","year":"2014","unstructured":"Chen W-L, Chen Y-M, Chu H-S, et al. Mechanisms Controlling the effects of bevacizumab (avastin) on the inhibition of early but not late formed corneal neovascularization. PLoS ONE. 2014;9(4):e94205. https:\/\/doi.org\/10.1371\/journal.pone.0094205.","journal-title":"PLoS ONE."},{"issue":"4","key":"309_CR98","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1167\/iovs.08-1997","volume":"50","author":"W-L Chen","year":"2009","unstructured":"Chen W-L, Lin C-T, Lin N-T, et al. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis. Investig Opthalmol Vis Sci. 2009;50(4):1659. https:\/\/doi.org\/10.1167\/iovs.08-1997.","journal-title":"Investig Opthalmol Vis Sci."},{"issue":"12","key":"309_CR99","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1167\/iovs.09-4571","volume":"51","author":"CT Lin","year":"2010","unstructured":"Lin CT, Hu FR, Kuo KT, et al. The different effects of early and late bevacizumab (Avastin) injection on inhibiting corneal neovascularization and conjunctivalization in rabbit limbal insufficiency. Investig Ophthalmol Vis Sci. 2010;51(12):6277\u201385.","journal-title":"Investig Ophthalmol Vis Sci."},{"issue":"8","key":"309_CR100","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/ICO.0b013e31823f8f7a","volume":"31","author":"Y Koenig","year":"2012","unstructured":"Koenig Y, Bock F, Kruse FE, Stock K, Cursiefen C. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with Anti-VEGFs. Cornea. 2012;31(8):887\u201392.","journal-title":"Cornea"},{"key":"309_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/178132","volume":"2014","author":"D Krizova","year":"2014","unstructured":"Krizova D, Vokrojova M, Liehneova K, Studeny P. Treatment of corneal neovascularization using anti-VEGF bevacizumab. J Ophthalmol. 2014;2014:1\u20138.","journal-title":"J Ophthalmol."},{"issue":"1","key":"309_CR102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s10792-017-0786-x","volume":"39","author":"HJ Yoon","year":"2019","unstructured":"Yoon HJ, Kim MK, Seo KY, Ueta M, Yoon KC. Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome. Int Ophthalmol. 2019;39(1):55\u201362.","journal-title":"Int Ophthalmol."},{"key":"309_CR103","doi-asserted-by":"publisher","unstructured":"Kim RY, Chung SK, Kim MS, Ra H. Effects of combined photodynamic therapy and topical bevacizumab treatment on corneal neovascularization in rabbits. Cornea. 2016;35(12):1615\u201320. https:\/\/doi.org\/10.1097\/ICO.0000000000001016.","DOI":"10.1097\/ICO.0000000000001016"},{"issue":"10","key":"309_CR104","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1097\/ICO.0b013e318180e50f","volume":"27","author":"G Gerten","year":"2008","unstructured":"Gerten G. Bevacizumab (avastin) and argon laser to treat neovascularization in corneal transplant surgery. Cornea. 2008;27(10):1195\u20139.","journal-title":"Cornea"},{"issue":"2","key":"309_CR105","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.sjopt.2017.02.008","volume":"31","author":"T Al-Debasi","year":"2017","unstructured":"Al-Debasi T, Al-Bekairy A, Al-Katheri A, Al Harbi S, Mansour M. Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization. Saudi J Ophthalmol. 2017;31(2):99\u2013105. https:\/\/doi.org\/10.1016\/j.sjopt.2017.02.008.","journal-title":"Saudi J Ophthalmol"},{"issue":"4","key":"309_CR106","first-page":"444","volume":"8","author":"OB Voiculescu","year":"2015","unstructured":"Voiculescu OB, Voinea LM, Alexandrescu C. Corneal neovascularization and biological therapy. J Med Life. 2015;8(4):444\u20138.","journal-title":"J Med Life."},{"issue":"2","key":"309_CR107","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"TM O\u2019Connor","year":"2004","unstructured":"O\u2019Connor TM, O\u2019Connell J, O\u2019Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201(2):167\u201380. https:\/\/doi.org\/10.1002\/jcp.20061.","journal-title":"J Cell Physiol"},{"issue":"3","key":"309_CR108","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1167\/iovs.17-23198","volume":"59","author":"M Barbariga","year":"2018","unstructured":"Barbariga M, Fonteyne P, Ostadreza M, Bignami F, Rama P, Ferrari G. Substance P modulation of human and murine corneal neovascularization. Investig Ophthalmol Vis Sci. 2018;59(3):1305\u201312.","journal-title":"Investig Ophthalmol Vis Sci."},{"issue":"7","key":"309_CR109","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1111\/aos.13304","volume":"95","author":"F Bignami","year":"2017","unstructured":"Bignami F, Lorusso A, Rama P, Ferrari G. Growth inhibition of formed corneal neovascularization following fosaprepitant treatment. Acta Ophthalmol. 2017;95(7):e641\u20138.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"309_CR110","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/bjo.72.12.900","volume":"72","author":"RJ Marsh","year":"1988","unstructured":"Marsh RJ. Argon laser treatment of lipid keratopathy. Br J Ophthalmol. 1988;72(12):900\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"309_CR111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1442-9071.2004.00764.x","volume":"32","author":"J Peter","year":"2004","unstructured":"Peter J, Fraenkel G, Goggin M, Drew A. Fluorescein angiographic monitoring of corneal vascularization in lipid keratopathy. Clin Exp Ophthalmol. 2004;32(1):78\u201380.","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"309_CR112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/bjo.66.2.127","volume":"66","author":"RJ Marsh","year":"1982","unstructured":"Marsh RJ, Marshall J. Treatment of lipid keratopathy with the argon laser. Br J Ophthalmol. 1982;66(2):127\u201335.","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"309_CR113","first-page":"2148","volume":"41","author":"CT Pillai","year":"2000","unstructured":"Pillai CT, Dua HS, Hossain P. Fine needle diathermy occlusion of corneal vessels. Invest Ophthalmol Vis Sci. 2000;41(8):2148\u201353.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"309_CR114","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/bjophthalmol-2014-304891","volume":"98","author":"LA Faraj","year":"2014","unstructured":"Faraj LA, Elalfy MS, Said DG, Dua HS. Fine needle diathermy occlusion of corneal vessels. Br J Ophthalmol. 2014;98(9):1287\u201390.","journal-title":"Br J Ophthalmol"},{"key":"309_CR115","doi-asserted-by":"publisher","unstructured":"Wertheim MS, Cook SD, Knox-Cartwright NE, Van D Le, Tole DM. Electrolysis-needle cauterization of corneal vessels in patients with lipid keratopathy. Cornea. 2007;26(2):230\u20131. https:\/\/doi.org\/10.1097\/01.ico.0000248383.09272.ee.","DOI":"10.1097\/01.ico.0000248383.09272.ee"},{"key":"309_CR116","doi-asserted-by":"publisher","unstructured":"Vanathi M, Panda A, Vengayil S, Chaudhuri Z, Dada T. Pediatric keratoplasty. Surv Ophthalmol. 2009;54(2):245\u201371. https:\/\/doi.org\/10.1016\/j.survophthal.2008.12.011.","DOI":"10.1016\/j.survophthal.2008.12.011"},{"issue":"11","key":"309_CR117","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1001\/jama.1981.03310360043023","volume":"245","author":"VP Chuang","year":"1981","unstructured":"Chuang VP. Chemoembolization: transcatheter management of neoplasms. JAMA 1981;245(11):1151\u20132. https:\/\/doi.org\/10.1001\/jama.1981.03310360043023.","journal-title":"JAMA"},{"key":"309_CR118","doi-asserted-by":"crossref","unstructured":"Spiteri N, Romano V, Zheng Y, et al. Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization. Ophthalmology. 2015;122(6):1079\u201384.","DOI":"10.1016\/j.ophtha.2015.02.012"},{"issue":"4","key":"309_CR119","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3129\/i09-068","volume":"44","author":"S Bearelly","year":"2009","unstructured":"Bearelly S, Rao S, Fekrat S. Anaphylaxis following intravenous fluorescein angiography in a vitreoretinal clinic: report of 4 cases. Can J Ophthalmol. 2009;44(4):444\u20135.","journal-title":"Can J Ophthalmol"},{"issue":"7","key":"309_CR120","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1097\/ICO.0000000000001931","volume":"38","author":"SY Chan","year":"2019","unstructured":"Chan SY, Pan CT, Feng Y. Localization of corneal neovascularization using optical coherence tomography angiography. Cornea. 2019;38(7):888\u201395.","journal-title":"Cornea"}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-020-00309-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-020-00309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:15:15Z","timestamp":1634256915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-020-00309-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,15]]},"references-count":120,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1007\/s40123-020-00309-y","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,15]]},"assertion":[{"value":"19 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}